AIMIL Pharmaceuticals India Limited has registered its presence in the ongoing Indo-American Wellness conclave in Santa Clara, US.
AIMIL with it's strong brand family will showcase it prowess in the most sought segment Non-Communicable Diseases (NCDs) in the event that will showcase different products related to Ayurveda yoga, herbal and natural medicine.
Executive Director of AIMIL said that to improve its ranking in wellness index, USA is looking towards herbal products, and it is a matter of pride for all of us. Moreover anti-diabetic drugs are usually, first developed by developed countries and then sold in India. However, this is for the first time that we would be showcasing indigenously-developed anti-diabetic drug to the world, he commented while talking about the CSIR developed anti-diabetic drug BGR-34 which is being showcased at the summit.